secwatch.observer — SEC 8-K summary
======================================

Issuer:     Matinas BioPharma Holdings, Inc. (MTNB)
CIK:        0001582554
Form:       8-K
Filed at:   2025-05-02T23:59:59+00:00
Accession:  0001641172-25-008417
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.02, 5.08, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Matinas BioPharma reduces quorum threshold, adds change-in-control bonuses for CEO/CFO, schedules annual meeting
--------------------------------------------------------------------------------

- Board reduced stockholder quorum from majority to one-third of voting power to facilitate meetings.
- CEO Jerome Jabbour eligible for retention bonus up to $299,000 if change in control occurs before March 31, 2026.
- CFO Keith Kucinski eligible for retention bonus up to $166,400 under same change-in-control terms.
- 2025 annual meeting set for June 23, 2025; record date May 1, 2025.
- Stockholder proposals and nominations must be received by May 12, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582554/000164117225008417/0001641172-25-008417-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582554/000164117225008417/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-008417

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer